Novel CDK19-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake-Reference-Cited by-同舟云学术

Novel CDK19-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake

Published:2024-04-03 Issue:8 Volume:67 Page:6726-6737
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Dai Dong¹²,Yu Jiang³,Gou Wenfeng³,Yang Shuangmeng³,Li Yanli³,Wang Ziyang²,Yang Zhao¹,Huang Ting³,Li Panfeng³,Zhu Tong³,Hou Wenbin³,Zhao Yu³^ORCID,Xu Wengui¹,Li Yiliang³^ORCID

Affiliation:

1. Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for China, Tianjin 300060, China

2. Department of Molecular Medicine, Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer, Tianjin 300308, China

3. Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China

Funder

Chinese Academy of Medical Sciences

Tianjin Municipal Science and Technology Program

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00281

Reference40 articles.

1. Current status and future perspective of radiopharmaceuticals in China

2. Bench to Bedside: Albumin Binders for Improved Cancer Radioligand Therapies

3. Theranostic Gallium Siderophore Ciprofloxacin Conjugate with Broad Spectrum Antibiotic Potency

4. Radiotracer Development for Bacterial Imaging

5. The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO